TNF and breast cancer: According to the role of complex gangliosides, especially GD2, in breast cancer cells EMT and aggressiveness, the increased expression of GD2 in breast cancer cells under TNF treatment could establish a link between the presence of pro-inflammatory cytokines at the tumor site environment, expression of complex gangliosides and EMT, resulting in more aggressive cells with increased tumorigenicity and increased resistance to treatment.